<DOC>
	<DOCNO>NCT03099525</DOCNO>
	<brief_summary>The objective single center , prospective , non-interventional cohort understand patient characteristic , general treatment pattern , effectiveness/safety conventional disease modify antirheumatic drug ( DMARD ) biologic DMARD treatment rheumatoid arthritis patient ILD real-world setting</brief_summary>
	<brief_title>Treatment Outcome Prognostic Factors Rheumatoid Arthritis ( RA ) Patients With Interstitial Lung Disease ( ILD )</brief_title>
	<detailed_description>Primary objective : Comparison prognosis RA-ILD RA-non ILD patient Secondary objective 1 . Identification prognostic factor aggravation factor ILD RA-ILD patient 2 . Identification association ILD autoantibody profile RA-ILD patient 3 . Comparison RA disease activity control RA-ILD RA-non ILD patient use disease activity score ( DAS ) 28-erythrocyte sedimentation ratio ( ESR ) , DAS28 C-reactive protein ( CRP ) , simple disease activity index ( SDAI ) clinical disease activity index ( CDAI ) 4 . Comparison biologic non-biologic DMARD treatment response RA-ILD patient use disease activity parameters The study population adult RA patient check chest compute tomography ( CT ) scan within 2 year enrollment . No additional visit laboratory test do outside routine clinical practice RA-non ILD patient . For RA-ILD patient , high resolution compute tomography ( HRCT ) , pulmonary function test ( PFT ) 6-min walk test examine annually identify progression ILD . Selection medication include conventional DMARDs , biologic DMARDs , glucocorticoid , inhaler , dose treatment duration discretion investigator .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>A . Patients satisfy 1987 American college rheumatology ( ACR ) 2010 ACR/EULAR classification criterion RA adult patient Patients 19 year old Patients check chest CT scan within 2 year Patients provide write consent participate study B . Patients age 19 year old Patients pregnant Patients dose provide write consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>